Skip to content
TrialScanner

NCT02820961

Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer

Phase 1CompletedSNDXLead

Registry record

Lead sponsor
Syndax Pharmaceuticals
Conditions
Breast Cancer; Estrogen Receptor Positive Breast Cancer
Primary completion
Sep 10, 2018Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02820961 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02820961: Drug-Drug Interaction Study... | TrialScanner